University of California San Francisco

Mi-Ok Kim PhD, MS, MA

Mi-Ok Kim, PhD, MS, MA
Mi-Ok Kim PhD, MS, MA

Professor
Department of Epidemiology & Biostatistics
University of California San Francisco
 

Address

1450 Third Street, #285
San Francisco, CA 94158
United States

Email: [email protected]

ORCID: 0000-0002-7712-3653

Education

Institution Degree Dept or School End Date
University of Illinois at Urbana-Champaign MS Statistics 2003
University of Illinois at Urbana-Champaign PhD Statistics 2003

Awards & Honors

Award Conferred By Date
Crohn’s and Colitis Foundation Uniting to Care and Cure Award Crohn’s and Colitis Foundation of America 2017

Grants and Funding

  • Mixed Data Meta-analysis: Integration of Individual Participant and Aggregate Data | PCORI | 2021-11-01 - 2024-10-31 | Role: PI
  • Cancer Center Support Grant | NIH | 1999-08-05 - 2023-05-31 | Role: Biostatistics and Population Research Shared Resource Director
  • Risk Stratification & Identification of immunogenic and microbial markers of rapid disease progression in children with Crohn’s disease | CCFA | 2008-07-01 - 2018-12-31 | Role: Biostatistics Core Director
  • Propensity Score-based Methods for CER Using Multilevel Data: What Works Best When | PCORI | 2015-01-01 - 2018-06-30 | Role: PI
  • Rigor of Multi-Registry CER Studies: Towards Patient-Centered Treatment Planning | NIH | 2014-08-01 - 2016-07-31 | Role: Principal Investigator
  • Collaborative Research: Extension of Quantile Regression and Empirical Likelihood Analysis for Censored Data | National Science Foundation (NSF) | 2010-09-01 - 2013-08-31 | Role: PI
  • Empirical Likelihood Bayes Analysis of Quantile Regression Model | NIH | 2009-07-01 - 2011-09-30 | Role: Principal Investigator
  • Empirical Likelihood Inference of Censored Quantile Regression | National Science Foundation (NSF) | 2006-06-01 - 2009-05-31 | Role: Co-Primary Investigator

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 121
  1. Patient-Derived Xenograft Models of Fanconi Anemia-Associated Head and Neck Cancer Identify Personalized Therapeutic Strategies.
    Grandis J, Li H, Harrison BA, Webster AL, Pucilowska J, Nguyen A, Lee J, Mills GB, Gencel-Augusto J, Zeng Y, Long SR, Kim MO, Lee RH, Kutler DI, Scognamiglio T, Brandwein-Weber M, Urken M, Khodos I, de Stanchina E, Lin YC, Donovan FX, Chandrasekharappa SC, Jung M, Sanders MA, Smogorzewska A, Johnson DE| | PubMed
  2. Multi-institutional analysis of incidence and risks for late-onset immune toxicity in breast cancer.
    Jacob S, Fisch S, Face C, Blum K, Chengappa M, Chaudhry S, LeVee A, Baclig NV, Soliman A, Huppert LA, Quandt Z, Quintal L, Idossa D, Melisko M, Chien AJ, Kim MO, Mortimer J, McCann K, Blaes A, Rugo HS| | PubMed
  3. Comparative study of intra- and inter-observer variability in manual scoring of HER2 immunohistochemical stains on glass slides versus paired digital images with emphasis on the low end of the expression spectrum.
    Xiao A, Vohra P, Chen YY, Ung L, Kim MO, Geradts J| | PubMed
  4. Blockade of the PGE2 Pathway Inhibits the Growth of PTEN-Deficient HNSCC Tumors.
    Nguyen JP, Na'ara S, Woerner LC, VanLandingham NK, Hoerner M, Santuray RT, Blum K, Kim MO, Johnson DE, Grandis JR| | PubMed
  5. Multicenter retrospective cohort study of the sequential use of the antibody-drug conjugates (ADCs) trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) in patients with HER2-low metastatic breast cancer (MBC).
    Huppert LA, Mahtani R, Fisch S, Dempsey N, Premji S, Raimonde A, Jacob S, Quintal L, Melisko M, Chien J, Sandoval A, Carcas L, Ahluwalia M, Harpalani N, Hoppenworth J, Blaes A, Blum K, Kim MO, Idossa D, Rao R, Giridhar KV, Rugo HS| | PubMed
  6. National yearly cost of breast cancer screening in the USA and projected cost of advocated guidelines: a simulation study with life table modelling.
    Badal K, Staib J, Tice JA, Kim MO, Eklund M, Wilson L, Dacosta Byfield S, Catlett K, Maffey L, Soonavala R, Shieh Y, Esserman LJ| | PubMed
  7. A pooled analysis evaluating prognostic significance of Residual Cancer Burden in invasive lobular breast cancer.
    Mukhtar RA, Gottipati S, Yau C, López-Tarruella S, Earl H, Hayward L, Hiller L, Osdoit M, van der Noordaa M, de Croze D, Hamy AS, Laé M, Reyal F, Sonke GS, Steenbruggen TG, van Seijen M, Wesseling J, Martín M, Del Monte-Millán M, Boughey JC, Goetz MP, Hoskin T, Valero V, Edge SB, Abraham JE, Bartlett JMS, Caldas C, Dunn J, Provenzano E, Sammut SJ, Thomas JS, Graham A, Hall P, Mackintosh L, Fan F, Godwin AK, Schwensen K, Sharma P, DeMichele AM, Cole K, Pusztai L, Kim MO, J van 't Veer L, Cameron D, Esserman LJ, Fraser Symmans W| | PubMed
  8. Skin Cancer Diagnosis by Lesion, Physician, and Examination Type: A Systematic Review and Meta-Analysis.
    Chen JY, Fernandez K, Fadadu RP, Reddy R, Kim MO, Tan J, Wei ML| | PubMed
  9. Decomposition of longitudinal disparities: an application to the fetal growth-singletons study.
    Lee SK, Kim S, Kim MO, Grantz KL, Hong HG| | PubMed
  10. Neutrophil-to-Lymphocyte Ratio and Pembrolizumab Outcomes in Oral Cavity Squamous Cell Carcinoma.
    Truong AA, Lee RH, Wu X, Algazi AP, Kang H, El-Sayed IH, George JR, Heaton CM, Ryan WR, Jeon Y, Kim MO, Ha PK, Wai KC| | PubMed
  11. The role of ethnic enclaves and neighborhood socioeconomic status in invasive breast cancer incidence rates among Asian American, Native Hawaiian, and Pacific Islander females in California.
    Truong A, McKinley M, Gomez SL, Kim MO, Shariff-Marco S, Cheng I| | PubMed
  12. Institutional Conversion to Energy-Efficient Ultra-Low Freezers Decreases Carbon Footprint and Reduces Energy Costs.
    Shehu D, Kim MO, Rosendo J, Krogan N, Morgan DO, Guglielmo BJ| | PubMed
  13. Designing monitoring strategies for deployed machine learning algorithms: navigating performativity through a causal lens
    Jean Feng, Adarsh Subbaswamy, Alexej Gossmann, Harvineet Singh, Berkman Sahiner, Mi-Ok Kim, Gene Anthony Pennello, Nicholas Petrick, Romain Pirracchio, Fan Xia| | UCSF Research Profile
  14. QUANTILE REGRESSION DECOMPOSITION ANALYSIS OF DISPARITY RESEARCH USING COMPLEX SURVEY DATA: APPLICATION TO DISPARITIES IN BMI AND TELOMERE LENGTH BETWEEN U.S. MINORITY AND WHITE POPULATION GROUPS.
    Hong HG, Graubard BI, Gastwirth JL, Kim MO| | PubMed
  15. Differences in Acute Postoperative Opioid Use by English Proficiency, Race, and Ethnicity After Total Knee and Hip Arthroplasty.
    Joo H, Nguyen K, Kolodzie K, Chen LL, Kim MO, Manuel S| | PubMed
  16. C5aR plus MEK inhibition durably targets the tumor milieu and reveals tumor cell phagocytosis.
    Perrino MR, Ahmari N, Hall A, Jackson M, Na Y, Pundavela J, Szabo S, Woodruff TM, Dombi E, Kim MO, Köhl J, Wu J, Ratner N| | PubMed
  17. Characterizing attitudes related to future child-bearing in young women diagnosed with early-stage breast cancer.
    Umashankar S, Li M, Blevins K, Kim MO, Majure M, Park J, Huppert LA, Melisko M, Rugo HS, Esserman L, Chien AJ| | PubMed
  18. Breastfeeding and Once-Daily Small-Volume Formula Supplementation to Prevent Infant Growth Impairment.
    Flaherman VJ, Murungi J, Bale C, Dickinson S, Chen X, Namiiro F, Nankunda J, Pollack LM, Laleau V, Kim MO, Allison DB, Ginsburg AS, Braima de Sa A, Nankabirwa V| | PubMed
  19. Simultaneous selection and incorporation of consistent external aggregate information.
    Huang Y, Huang CY, Kim MO| | PubMed
  20. Bayesian adaptive design for covariate-adaptive historical control information borrowing.
    Jin H, Kim MO, Scheffler A, Jiang F| | PubMed
  21. Opposing effects of KDM6A and JDP2 on glucocorticoid sensitivity in T-ALL.
    Levinson AL, Tjoa K, Huang B, Meyer LK, Kim MO, Brady SW, Zhang J, Shannon K, Wandler AM| | PubMed
  22. Broad- Versus Narrow-Spectrum Perioperative Antibiotics and Outcomes in Pediatric Congenital Heart Disease Surgery: Analysis of the Vizient Clinical Data Base.
    Cooch PB, Kim MO, Swami N, Tamma PD, Tabbutt S, Steurer MA, Wattier RL| | PubMed
  23. Neighborhood attributes and cardiovascular disease risk in breast cancer survivors: The Pathways Study.
    Conroy SM, Von Behren J, Kwan ML, Kushi LH, Kim MO, Iribarren C, Roh JM, Laurent CA, Thomsen C, Chu JN, Greenlee H, Gomez SL, Shariff-Marco S| | PubMed
  24. Combining SOS1 and MEK Inhibitors in a Murine Model of Plexiform Neurofibroma Results in Tumor Shrinkage.
    Jackson M, Ahmari N, Wu J, Rizvi TA, Fugate E, Kim MO, Dombi E, Arnhof H, Boehmelt G, Düchs MJ, Long CJ, Maier U, Trapani F, Hofmann MH, Ratner N| | PubMed
  25. Towards a Post-Market Monitoring Framework for
    Machine Learning-based Medical Devices: A case
    study
    Jean Feng, Adarsh Subbaswamy, Alexej Gossmann, Harvineet Singh, Berkman Sahiner, Mi-Ok Kim, Gene Pennello, Nicholas Petrick, Romain Pirracchio, and Fan Xia| | UCSF Research Profile
  26. Optimizing intervention tools to improve nutrition and physical activity for colorectal cancer survivors (Tools To Be Fit): Study protocol of a randomized factorial experiment.
    Kenfield SA, Philip EJ, Phillips SM, Meyerhardt JA, Chan JM, Atreya CE, Kim MO, Harris Q, Steiding P, Macaire G, McCullough ML, Piawah S, Johnson WY, Kurttila FA, Lewis WL, Pesmen C, Watson Y, Van Blarigan EL| | PubMed
  27. Assessing Unique Risk Factors for COVID-19 Complications Among Cancer Patients: A Multi-ethnic Cohort Study.
    Borno HT, Kim MO, Tolstykh I, Lin A, Hong JC, Yousefi S, Zhang S, McKay RR, Harismendy O, Razavi P, Cinar P, Rugo H, Koshkin VS, Rabow M, Wang C, Bailey A, Small EJ| | PubMed
  28. Clinical characteristics and outcomes in patients with metastatic breast cancer and pseudocirrhosis: a single center retrospective cohort study.
    Huppert LA, Walker Z, Li M, Kim MO, Callan J, Brandman D, Majure M, Melisko ME, Rugo HS, Behr S, Chien AJ| | PubMed
  29. STAT3 Activation as a Predictive Biomarker for Ruxolitinib Response in Head and Neck Cancer.
    Qureshy Z, Li H, Zeng Y, Rivera J, Cheng N, Peterson CN, Kim MO, Ryan WR, Ha PK, Bauman JE, Wang SJ, Long SR, Johnson DE, Grandis JR| | PubMed
  30. Effect of Social Needs Case Management on Hospital Use Among Adult Medicaid Beneficiaries : A Randomized Study.
    Brown DM, Hernandez EA, Levin S, De Vaan M, Kim MO, Lynch C, Roth A, Brewster AL| | PubMed
  31. COVID-19 Outcomes Among Patients With Cancer: Observations From the University of California Cancer Consortium COVID-19 Project Outcomes Registry.
    Borno HT, Kim MO, Hong JC, Yousefi S, Lin A, Tolstykh I, Zhang S, McKay RR, Harismendy O, Cinar P, Rugo H, Koshkin VS, Rabow M, Wang C, Bailey A, Small EJ| | PubMed
  32. Randomized controlled trial of early, small-volume formula supplementation among newborns: A study protocol.
    Ginsburg AS, Braima de Sa A, Nankabirwa V, Co R, Murungi J, Kim MO, Brim R, Namiiro F, Namugga O, Hartigan-O'Connor DJ, Roberts SB, Flaherman V| | PubMed
  33. Feasibility and Acceptability of a Physical Activity Tracker and Text Messages to Promote Physical Activity During Chemotherapy for Colorectal Cancer: Pilot Randomized Controlled Trial (Smart Pace II).
    Van Blarigan EL, Dhruva A, Atreya CE, Kenfield SA, Chan JM, Milloy A, Kim I, Steiding P, Laffan A, Zhang L, Piawah S, Fukuoka Y, Miaskowski C, Hecht FM, Kim MO, Venook AP, Van Loon K| | PubMed
  34. Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients.
    Yau C, Osdoit M, van der Noordaa M, Shad S, Wei J, de Croze D, Hamy AS, Laé M, Reyal F, Sonke GS, Steenbruggen TG, van Seijen M, Wesseling J, Martín M, Del Monte-Millán M, López-Tarruella S, I-SPY 2 Trial Consortium, Boughey JC, Goetz MP, Hoskin T, Gould R, Valero V, Edge SB, Abraham JE, Bartlett JMS, Caldas C, Dunn J, Earl H, Hayward L, Hiller L, Provenzano E, Sammut SJ, Thomas JS, Cameron D, Graham A, Hall P, Mackintosh L, Fan F, Godwin AK, Schwensen K, Sharma P, DeMichele AM, Cole K, Pusztai L, Kim MO, van 't Veer LJ, Esserman LJ, Symmans WF| | PubMed
  35. Therapeutic implications of activating noncanonical PIK3CA mutations in head and neck squamous cell carcinoma.
    Jin N, Keam B, Cho J, Lee MJ, Kim HR, Torosyan H, Jura N, Ng PK, Mills GB, Li H, Zeng Y, Barbash Z, Tarcic G, Kang H, Bauman JE, Kim MO, VanLandingham NK, Swaney DL, Krogan NJ, Johnson DE, Grandis JR| | PubMed
  36. Dynamic Risk Prediction for Hospital-Acquired Pressure Injury in Adult Critical Care Patients.
    Shui AM, Kim P, Aribindi V, Huang CY, Kim MO, Rangarajan S, Schorger K, Aldrich JM, Lee H| | PubMed
  37. Update on Phototherapy and Childhood Cancer in a Northern California Cohort.
    Digitale JC, Kim MO, Kuzniewicz MW, Newman TB| | PubMed
  38. Perioperative Normal Saline Administration and Delayed Graft Function in Patients Undergoing Kidney Transplantation: A Retrospective Cohort Study.
    Kolodzie K, Cakmakkaya OS, Boparai ES, Tavakol M, Feiner JR, Kim MO, Newman TB, Niemann CU| | PubMed
  39. Predictive generalized varying-coefficient longitudinal model.
    Kim S, Ryan Cho H, Kim MO| | PubMed
  40. PD-L1 is upregulated via BRD2 in head and neck squamous cell carcinoma models of acquired cetuximab resistance.
    Bhola NE, Njatcha C, Hu L, Lee ED, Shiah JV, Kim MO, Johnson DE, Grandis JR| | PubMed
  41. Synthesizing external aggregated information in the penalized Cox regression under population heterogeneity.
    Sheng Y, Sun Y, Huang CY, Kim MO| | PubMed
  42. Synthesizing external aggregated information in the presence of population heterogeneity: A penalized empirical likelihood approach.
    Sheng Y, Sun Y, Huang CY, Kim MO| | PubMed
  43. Effect of treatment center volume on outcomes in gastroenteropancreatic neuroendocrine tumor patients.
    Baeg K, Harris C, Naparst MS, Ahn E, Thapi S, Martin J, Rustgi S, Mhango G, Wisnivesky J, Kim MK| | PubMed
  44. Optimal treatment regimes for competing risk data using doubly robust outcome weighted learning with bi-level variable selection.
    He Y, Kim S, Kim MO, Saber W, Ahn KW| | PubMed
  45. MicroRNA-155 contributes to plexiform neurofibroma growth downstream of MEK.
    Na Y, Hall A, Choi K, Hu L, Rose J, Coover RA, Miller A, Hennigan RF, Dombi E, Kim MO, Subramanian S, Ratner N, Wu J| | PubMed
  46. Critical appraisal of Bayesian dynamic borrowing from an imperfectly commensurate historical control.
    Harun N, Liu C, Kim MO| | PubMed
  47. Residual tumor volume discriminates prognosis after surgery for neuroendocrine liver metastasis.
    Kasai Y, Hirose K, Corvera CU, Kim GE, Hope TA, Shih BE, Harun N, Kim MO, Warren RS, Bergsland EK, Nakakura EK| | PubMed
  48. Variation in Care in the Management of Children With Crohn's Disease: Data From a Multicenter Inception Cohort Study.
    Krishnakumar C, Ballengee CR, Liu C, Kim MO, Baker SS, Baldassano RN, Cohen SA, Crandall WV, Denson LA, Dubinsky MC, Evans J, Gokhale R, Griffiths A, Guthery SL, Oliva-Hemker M, Heyman MB, Keljo D, Kellermayer R, Leleiko NS, Mack DR, Markowitz JF, Moulton DE, Noe JD, Otley AR, Patel AS, Pfefferkorn M, Rabizadeh S, Rosh JR, Snapper S, Walters TD, Ziring D, Mondal K, Kappelman MD, Hyams JS, Kugathasan S| | PubMed
  49. Propensity score analysis for correlated subgroup effects.
    Liu SY, Liu C, Nehus E, Macaluso M, Lu B, Kim MO| | PubMed
  50. RUNX represses Pmp22 to drive neurofibromagenesis.
    Hall A, Choi K, Liu W, Rose J, Zhao C, Yu Y, Na Y, Cai Y, Coover RA, Lin Y, Dombi E, Kim M, Levanon D, Groner Y, Boscolo E, Pan D, Liu PP, Lu QR, Ratner N, Huang G, Wu J| | PubMed
  51. Cxcr3-expressing leukocytes are necessary for neurofibroma formation in mice.
    Fletcher JS, Wu J, Jessen WJ, Pundavela J, Miller JA, Dombi E, Kim MO, Rizvi TA, Chetal K, Salomonis N, Ratner N| | PubMed
  52. Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for PIK3CA-altered head and neck cancer.
    Hedberg ML, Peyser ND, Bauman JE, Gooding WE, Li H, Bhola NE, Zhu TR, Zeng Y, Brand TM, Kim MO, Jordan RCK, VandenBerg S, Olivas V, Bivona TG, Chiosea SI, Wang L, Mills GB, Johnson JT, Duvvuri U, Ferris RL, Ha P, Johnson DE, Grandis JR| | PubMed
  53. Age-of-diagnosis dependent ileal immune intensification and reduced alpha-defensin in older versus younger pediatric Crohn Disease patients despite already established dysbiosis.
    Haberman Y, Schirmer M, Dexheimer PJ, Karns R, Braun T, Kim MO, Walters TD, Baldassano RN, Noe JD, Rosh J, Markowitz J, Crandall WV, Mack DR, Griffiths AM, Heyman MB, Baker SS, Kellermayer R, Moulton D, Patel AS, Gulati AS, Steiner SJ, LeLeiko N, Otley A, Oliva-Hemker M, Ziring D, Kirschner BS, Keljo DJ, Guthery SL, Cohen SA, Snapper S, Evans J, Dubinsky M, Aronow B, Hyams JS, Kugathasan S, Huttenhower C, Xavier RJ, Denson LA| | PubMed
  54. STAT3 inhibition reduces macrophage number and tumor growth in neurofibroma.
    Fletcher JS, Springer MG, Choi K, Jousma E, Rizvi TA, Dombi E, Kim MO, Wu J, Ratner N| | PubMed
  55. COMPARISON OF EXTENDED EMPIRICAL LIKELIHOOD METHODS: SIZE AND SHAPE OF TEST BASED CONFIDENCE REGIONS
    Kim MO, Zhou M| | UCSF Research Profile
  56. Genome-Informed Targeted Therapy for Osteosarcoma.
    Sayles LC, Breese MR, Koehne AL, Leung SG, Lee AG, Liu HY, Spillinger A, Shah AT, Tanasa B, Straessler K, Hazard FK, Spunt SL, Marina N, Kim GE, Cho SJ, Avedian RS, Mohler DG, Kim MO, DuBois SG, Hawkins DS, Sweet-Cordero EA| | PubMed
  57. Estimating heterogeneous treatment effects for latent subgroups in observational studies.
    Kim HJ, Lu B, Nehus EJ, Kim MO| | PubMed
  58. Evolution of Pediatric Inflammatory Bowel Disease Unclassified (IBD-U): Incorporated With Serological and Gene Expression Profiles.
    Chandradevan R, Hofmekler T, Mondal K, Harun N, Venkateswaran S, Somineni HK, Ballengee CR, Kim MO, Griffiths A, Noe JD, Crandall WV, Snapper S, Rabizadeh S, Rosh JR, Walters TD, Bertha M, Dubinsky MC, Denson LA, Sauer CG, Markowitz JF, LeLeiko NS, Hyams JS, Kugathasan S| | PubMed
  59. Association Between Plasma Level of Collagen Type III Alpha 1 Chain and Development of Strictures in Pediatric Patients With Crohn's Disease.
    Ballengee CR, Stidham RW, Liu C, Kim MO, Prince J, Mondal K, Baldassano R, Dubinsky M, Markowitz J, Leleiko N, Hyams J, Denson L, Kugathasan S| | PubMed
  60. Bayesian selective response-adaptive design using the historical control.
    Kim MO, Harun N, Liu C, Khoury JC, Broderick JP| | PubMed
  61. Familial Association of Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in Inflammatory Bowel Disease.
    Wright SS, Trauernicht A, Bonkowski E, McCall CA, Maier EA, Bezold R, Lake K, Chalk C, Trapnell BC, Kim MO, Kugathasan S, Denson LA| | PubMed
  62. Transcriptional risk scores link GWAS to eQTLs and predict complications in Crohn's disease.
    Marigorta UM, Denson LA, Hyams JS, Mondal K, Prince J, Walters TD, Griffiths A, Noe JD, Crandall WV, Rosh JR, Mack DR, Kellermayer R, Heyman MB, Baker SS, Stephens MC, Baldassano RN, Markowitz JF, Kim MO, Dubinsky MC, Cho J, Aronow BJ, Kugathasan S, Gibson G| | PubMed
  63. Erratum to: Fertility preservation with ovarian stimulation and time to treatment in women with stage II-III breast cancer receiving neoadjuvant therapy.
    Chien AJ, Chambers J, Mcauley F, Kaplan T, Letourneau J, Hwang J, Kim MO, Melisko ME, Rugo HS, Esserman LJ, Rosen MP| | PubMed
  64. Graft survival of pediatric kidney transplant recipients selected for de novo steroid avoidance-a propensity score-matched study.
    Nehus EJ, Liu C, Lu B, Macaluso M, Kim MO| | PubMed
  65. Fertility preservation with ovarian stimulation and time to treatment in women with stage II-III breast cancer receiving neoadjuvant therapy.
    Chien AJ, Chambers J, Mcauley F, Kaplan T, Letourneau J, Hwang J, Kim MO, Melisko ME, Rugo HS, Esserman LJ, Rosen MP| | PubMed
  66. Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study.
    Kugathasan S, Denson LA, Walters TD, Kim MO, Marigorta UM, Schirmer M, Mondal K, Liu C, Griffiths A, Noe JD, Crandall WV, Snapper S, Rabizadeh S, Rosh JR, Shapiro JM, Guthery S, Mack DR, Kellermayer R, Kappelman MD, Steiner S, Moulton DE, Keljo D, Cohen S, Oliva-Hemker M, Heyman MB, Otley AR, Baker SS, Evans JS, Kirschner BS, Patel AS, Ziring D, Trapnell BC, Sylvester FA, Stephens MC, Baldassano RN, Markowitz JF, Cho J, Xavier RJ, Huttenhower C, Aronow BJ, Gibson G, Hyams JS, Dubinsky MC| | PubMed
  67. Multiple quantile regression analysis of longitudinal data: Heteroscedasticity and efficient estimation
    Cho H, Kim S, Kim MO| | UCSF Research Profile
  68. Rapid Lentiviral Transduction Preserves the Engraftment Potential of Fanca-/- Hematopoietic Stem Cells.
    Müller LU, Milsom MD, Kim MO, Schambach A, Schuesler T, Williams DA| | PubMed
  69. A comparison of safety and efficacy of cytotoxic versus molecularly targeted drugs in pediatric phase I solid tumor oncology trials.
    Dorris K, Liu C, Li D, Hummel TR, Wang X, Perentesis J, Kim MO, Fouladi M| | PubMed
  70. Frequency and risks associated with Clostridium difficile-associated diarrhea after pediatric solid organ transplantation: a single-center retrospective review.
    Ciricillo J, Haslam D, Blum S, Kim MO, Liu C, Paulsen G, Courter J, Danziger-Isakov L| | PubMed
  71. Random-effects meta-analysis for systematic reviews of phase I clinical trials: Rare events and missing data.
    Kim MO, Wang X, Liu C, Dorris K, Fouladi M, Song S| | PubMed
  72. Practical Use of Infliximab Concentration Monitoring in Pediatric Crohn Disease.
    Minar P, Saeed SA, Afreen M, Kim MO, Denson LA| | PubMed
  73. Efficient quantile marginal regression for longitudinal data with dropouts.
    Cho H, Hong HG, Kim MO| | PubMed
  74. Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation.
    Wu J, Keng VW, Patmore DM, Kendall JJ, Patel AV, Jousma E, Jessen WJ, Choi K, Tschida BR, Silverstein KA, Fan D, Schwartz EB, Fuchs JR, Zou Y, Kim MO, Dombi E, Levy DE, Huang G, Cancelas JA, Stemmer-Rachamimov AO, Spinner RJ, Largaespada DA, Ratner N| | PubMed
  75. Practice of Causal Inference with the Propensity of Being Zero or One: Assessing the Effect of Arbitrary Cutoffs of Propensity Scores
    Kang J, Chan W, Kim MO, Steiner PM| | UCSF Research Profile
  76. Runx1 contributes to neurofibromatosis type 1 neurofibroma formation.
    Li H, Zhao X, Yan X, Jessen WJ, Kim MO, Dombi E, Liu PP, Huang G, Wu J| | PubMed
  77. Preclinical assessments of the MEK inhibitor PD-0325901 in a mouse model of Neurofibromatosis type 1.
    Jousma E, Rizvi TA, Wu J, Janhofer D, Dombi E, Dunn RS, Kim MO, Masters AR, Jones DR, Cripe TP, Ratner N| | PubMed
  78. Corrigendum. Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature.
    Haberman Y, Tickle TL, Dexheimer PJ, Kim MO, Tang D, Karns R, Baldassano RN, Noe JD, Rosh J, Markowitz J, Heyman MB, Griffiths AM, Crandall WV, Mack DR, Baker SS, Huttenhower C, Keljo DJ, Hyams JS, Kugathasan S, Walters TD, Aronow B, Xavier RJ, Gevers D, Denson LA| | PubMed
  79. Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature.
    Haberman Y, Tickle TL, Dexheimer PJ, Kim MO, Tang D, Karns R, Baldassano RN, Noe JD, Rosh J, Markowitz J, Heyman MB, Griffiths AM, Crandall WV, Mack DR, Baker SS, Huttenhower C, Keljo DJ, Hyams JS, Kugathasan S, Walters TD, Aronow B, Xavier RJ, Gevers D, Denson LA| | PubMed
  80. Utility of neutrophil Fcγ receptor I (CD64) index as a biomarker for mucosal inflammation in pediatric Crohn's disease.
    Minar P, Haberman Y, Jurickova I, Wen T, Rothenberg ME, Kim MO, Saeed SA, Baldassano RN, Stephens M, Markowitz J, Rosh J, Crandall WV, Heyman MB, Mack DR, Griffiths AM, Baker SS, Hyams JS, Kugathasan S, Denson LA| | PubMed
  81. Outcome-adaptive randomization for a delayed outcome with a short-term predictor: imputation-based designs.
    Kim MO, Liu C, Hu F, Lee JJ| | PubMed
  82. Increased effectiveness of early therapy with anti-tumor necrosis factor-α vs an immunomodulator in children with Crohn's disease.
    Walters TD, Kim MO, Denson LA, Griffiths AM, Dubinsky M, Markowitz J, Baldassano R, Crandall W, Rosh J, Pfefferkorn M, Otley A, Heyman MB, LeLeiko N, Baker S, Guthery SL, Evans J, Ziring D, Kellermayer R, Stephens M, Mack D, Oliva-Hemker M, Patel AS, Kirschner B, Moulton D, Cohen S, Kim S, Liu C, Essers J, Kugathasan S, Hyams JS, PRO-KIIDS Research Group| | PubMed
  83. An intermediate alemtuzumab schedule reduces the incidence of mixed chimerism following reduced-intensity conditioning hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis.
    Marsh RA, Kim MO, Liu C, Bellman D, Hart L, Grimley M, Kumar A, Jodele S, Myers KC, Chandra S, Leemhuis T, Mehta PA, Bleesing JJ, Davies SM, Jordan MB, Filipovich AH| | PubMed
  84. Everolimus treatment of refractory epilepsy in tuberous sclerosis complex.
    Krueger DA, Wilfong AA, Holland-Bouley K, Anderson AE, Agricola K, Tudor C, Mays M, Lopez CM, Kim MO, Franz DN| | PubMed
  85. Oxandrolone for the treatment of bone marrow failure in Fanconi anemia.
    Rose SR, Kim MO, Korbee L, Wilson KA, Ris MD, Eyal O, Sherafat-Kazemzadeh R, Bollepalli S, Harris R, Jeng MR, Williams DA, Smith FO| | PubMed
  86. Increased prevalence of luminal narrowing and stricturing identified by enterography in pediatric Crohn's disease patients with elevated granulocyte-macrophage colony stimulating factor autoantibodies.
    Dykes DM, Towbin AJ, Bonkowski E, Chalk C, Bezold R, Lake K, Kim MO, Heubi JE, Trapnell BC, Podberesky DJ, Denson LA| | PubMed
  87. Granulocyte-macrophage colony-stimulating factor autoantibodies: a marker of aggressive Crohn's disease.
    Gathungu G, Kim MO, Ferguson JP, Sharma Y, Zhang W, Ng SM, Bonkowski E, Ning K, Simms LA, Croft AR, Stempak JM, Walker N, Huang N, Xiao Y, Silverberg MS, Trapnell B, Cho JH, Radford-Smith GL, Denson LA| | PubMed
  88. MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors.
    Jessen WJ, Miller SJ, Jousma E, Wu J, Rizvi TA, Brundage ME, Eaves D, Widemann B, Kim MO, Dombi E, Sabo J, Hardiman Dudley A, Niwa-Kawakita M, Page GP, Giovannini M, Aronow BJ, Cripe TP, Ratner N| | PubMed
  89. Allogeneic hematopoietic cell transplantation for XIAP deficiency: an international survey reveals poor outcomes.
    Marsh RA, Rao K, Satwani P, Lehmberg K, Müller I, Li D, Kim MO, Fischer A, Latour S, Sedlacek P, Barlogis V, Hamamoto K, Kanegane H, Milanovich S, Margolis DA, Dimmock D, Casper J, Douglas DN, Amrolia PJ, Veys P, Kumar AR, Jordan MB, Bleesing JJ, Filipovich AH| | PubMed
  90. Improved outcomes for stem cell transplant recipients requiring pediatric intensive care.
    Chima RS, Daniels RC, Kim MO, Li D, Wheeler DS, Davies SM, Jodele S| | PubMed
  91. Neurofibroma-associated macrophages play roles in tumor growth and response to pharmacological inhibition.
    Prada CE, Jousma E, Rizvi TA, Wu J, Dunn RS, Mayes DA, Cancelas JA, Dombi E, Kim MO, West BL, Bollag G, Ratner N| | PubMed
  92. A high-resolution analysis of process improvement: use of quantile regression for wait time.
    Choi D, Hoffman KA, Kim MO, McCarty D| | PubMed
  93. The fanconi anemia pathway limits human papillomavirus replication.
    Hoskins EE, Morreale RJ, Werner SP, Higginbotham JM, Laimins LA, Lambert PF, Brown DR, Gillison ML, Nuovo GJ, Witte DP, Kim MO, Davies SM, Mehta PA, Butsch Kovacic M, Wikenheiser-Brokamp KA, Wells SI| | PubMed
  94. Empirical Likelihood Analysis for the Heteroscedastic Accelerated Failure Time Model
    Zhou M, Kim MO and Bathke A| | UCSF Research Profile
  95. Journal of Agricultural, Biological, and Environmental Statistics
    Kim MO| | UCSF Research Profile
  96. Censored quantile regression for residual lifetimes.
    Kim MO, Zhou M, Jeong JH| | PubMed
  97. Semiparametric Approach to a Random Effects Quantile Regression Model.
    Kim MO, Yang Y| | PubMed
  98. Biomarkers for early detection of sickle nephropathy.
    Sundaram N, Bennett M, Wilhelm J, Kim MO, Atweh G, Devarajan P, Malik P| | PubMed
  99. Granulocyte macrophage-colony-stimulating factor autoantibodies and increased intestinal permeability in Crohn disease.
    Nylund CM, D'Mello S, Kim MO, Bonkowski E, Däbritz J, Foell D, Meddings J, Trapnell BC, Denson LA| | PubMed
  100. The impact of the 2009 H1N1 influenza pandemic on pediatric patients with sickle cell disease.
    George A, Benton J, Pratt J, Kim MO, Kalinyak KA, Kalfa TA, Joiner CH| | PubMed
  101. Preclincial testing of sorafenib and RAD001 in the Nf(flox/flox) ;DhhCre mouse model of plexiform neurofibroma using magnetic resonance imaging.
    Wu J, Dombi E, Jousma E, Scott Dunn R, Lindquist D, Schnell BM, Kim MO, Kim A, Widemann BC, Cripe TP, Ratner N| | PubMed
  102. The Timing of Alemtuzumab Significantly Impacts Mixed Chimerism and Acute Graft Versus Host Disease
    Marsh RA, Li D, Kim MO, Hart L, Joshi S, Jodele S, Mehta P, Jordan MB, Bleesing JJ, Davies SM, Filipovich AH| | UCSF Research Profile
  103. Numerical chromosomal changes and risk of development of myelodysplastic syndrome--acute myeloid leukemia in patients with Fanconi anemia.
    Mehta PA, Harris RE, Davies SM, Kim MO, Mueller R, Lampkin B, Mo J, Myers K, Smolarek TA| | PubMed
  104. Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation.
    Marsh RA, Vaughn G, Kim MO, Li D, Jodele S, Joshi S, Mehta PA, Davies SM, Jordan MB, Bleesing JJ, Filipovich AH| | PubMed
  105. Improved recipient survival with maternal nifedipine in twin-twin transfusion syndrome complicated by TTTS cardiomyopathy undergoing selective fetoscopic laser photocoagulation.
    Crombleholme TM, Lim FY, Habli M, Polzin W, Jaekle R, Michelfelder E, Cnota J, Liu C, Kim MO| | PubMed
  106. Mammary gland differentiation by early life exposure to enantiomers of the soy isoflavone metabolite equol.
    Brown NM, Belles CA, Lindley SL, Zimmer-Nechemias L, Witte DP, Kim MO, Setchell KD| | PubMed
  107. A randomized controlled trial of growth hormone in active pediatric Crohn disease.
    Denson LA, Kim MO, Bezold R, Carey R, Osuntokun B, Nylund C, Willson T, Bonkowski E, Li D, Ballard E, Collins M, Moyer MS, Klein DJ| | PubMed
  108. Statistical issues in longitudinal data analysis for treatment efficacy studies in the biomedical sciences.
    Liu C, Cripe TP, Kim MO| | PubMed
  109. The chemopreventive action of equol enantiomers in a chemically induced animal model of breast cancer.
    Brown NM, Belles CA, Lindley SL, Zimmer-Nechemias LD, Zhao X, Witte DP, Kim MO, Setchell KD| | PubMed
  110. Patients with X-linked lymphoproliferative disease due to BIRC4 mutation have normal invariant natural killer T-cell populations.
    Marsh RA, Villanueva J, Kim MO, Zhang K, Marmer D, Risma KA, Jordan MB, Bleesing JJ, Filipovich AH| | PubMed
  111. Ectopic HOXB4 overcomes the inhibitory effect of tumor necrosis factor-{alpha} on Fanconi anemia hematopoietic stem and progenitor cells.
    Milsom MD, Schiedlmeier B, Bailey J, Kim MO, Li D, Jansen M, Ali AM, Kirby M, Baum C, Fairbairn LJ, Williams DA| | PubMed
  112. Combined multiple testing by censored empirical likelihood
    Bathke A, Kim, MO, Zhou M| | UCSF Research Profile
  113. Granulocyte-macrophage colony-stimulating factor autoantibodies in murine ileitis and progressive ileal Crohn's disease.
    Han X, Uchida K, Jurickova I, Koch D, Willson T, Samson C, Bonkowski E, Trauernicht A, Kim MO, Tomer G, Dubinsky M, Plevy S, Kugathsan S, Trapnell BC, Denson LA| | PubMed
  114. Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.
    Johansson G, Mahller YY, Collins MH, Kim MO, Nobukuni T, Perentesis J, Cripe TP, Lane HA, Kozma SC, Thomas G, Ratner N| | PubMed
  115. Evaluation of orthodontic mini-implant anchorage in premolar extraction therapy in adolescents.
    Garfinkle JS, Cunningham LL, Beeman CS, Kluemper GT, Hicks EP, Kim MO| | PubMed
  116. Rapid lentiviral transduction preserves the engraftment potential of Fanca(-/-) hematopoietic stem cells.
    Müller LU, Milsom MD, Kim MO, Schambach A, Schuesler T, Williams DA| | PubMed
  117. Empirical Likelihood for Linear Models in the Presence of Nuisance Parameters
    Kim MO, Zhou M| | UCSF Research Profile
  118. Small pituitary size in children with Fanconi anemia.
    Sherafat-Kazemzadeh R, Mehta SN, Care MM, Kim MO, Williams DA, Rose SR, Fanconi Anemia Comprehensive Care Center| | PubMed
  119. Quantile Regression with Varying Coefficients
    Kim MO| | UCSF Research Profile
  120. Quantile Regression with Shape-Constrained Varying Coefficients
    Kim MO| | UCSF Research Profile
  121. On Marginal Estimation in a Semiparametric Model for Longitudinal Data with Time-Independent Covariates
    He X, Kim MO| | UCSF Research Profile